DK581989A - Steroidlotion - Google Patents

Steroidlotion

Info

Publication number
DK581989A
DK581989A DK581989A DK581989A DK581989A DK 581989 A DK581989 A DK 581989A DK 581989 A DK581989 A DK 581989A DK 581989 A DK581989 A DK 581989A DK 581989 A DK581989 A DK 581989A
Authority
DK
Denmark
Prior art keywords
steroid
lotion
steroid lotion
corticosteroids
hydro
Prior art date
Application number
DK581989A
Other languages
English (en)
Other versions
DK581989D0 (da
Inventor
Joel A Sequeira
Farah J Munayyer
Rebecca Galeos
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21982389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK581989(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK581989A publication Critical patent/DK581989A/da
Publication of DK581989D0 publication Critical patent/DK581989D0/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK581989A 1987-05-21 1989-11-20 Steroidlotion DK581989D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/053,172 US4775529A (en) 1987-05-21 1987-05-21 Steroid lotion
PCT/US1988/001606 WO1988009174A1 (en) 1987-05-21 1988-05-20 Steroid lotion

Publications (2)

Publication Number Publication Date
DK581989A true DK581989A (da) 1989-11-20
DK581989D0 DK581989D0 (da) 1989-11-20

Family

ID=21982389

Family Applications (1)

Application Number Title Priority Date Filing Date
DK581989A DK581989D0 (da) 1987-05-21 1989-11-20 Steroidlotion

Country Status (22)

Country Link
US (1) US4775529A (da)
EP (2) EP0292893B2 (da)
JP (1) JP2572124B2 (da)
KR (2) KR890701109A (da)
AT (1) ATE77745T1 (da)
AU (1) AU616188B2 (da)
CA (1) CA1307207C (da)
DE (1) DE3872521T3 (da)
DK (1) DK581989D0 (da)
ES (1) ES2032898T5 (da)
FI (1) FI95350C (da)
GR (2) GR3005762T3 (da)
HK (1) HK60595A (da)
IE (1) IE60546B1 (da)
IL (1) IL86440A (da)
MX (1) MX9203285A (da)
MY (1) MY103280A (da)
NO (1) NO175762C (da)
NZ (1) NZ224707A (da)
PH (1) PH24528A (da)
WO (1) WO1988009174A1 (da)
ZA (1) ZA883566B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942158A (en) * 1988-10-13 1990-07-17 Eastman Kodak Transdermal steroid penetrant compositions and methods utilizing isopropanol and isobutanol
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
PL165803B1 (pl) * 1990-09-10 1995-02-28 Schering Corp Sposób wytwarzania nowego monohydratu 9a, 21-dichloro-16-a metylo-1,4-pregnadieno-11 ß , 17a-diolo-3,20-diono-17-(2’furanokarboksylanu) PL PL PL PL
US6127353A (en) * 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
NZ278198A (en) * 1993-12-21 1997-12-19 Schering Corp Pharmaceutical compositions comprising mometasone furoate and salicyclic acid; use in treatment of psoriasis
DE4344697A1 (de) * 1993-12-27 1995-06-29 Beiersdorf Ag Corticosteroide enthaltende W/O-Lotion
US7566460B2 (en) * 1995-06-22 2009-07-28 3M Innovative Properties Company Stable hydroalcoholic compositions
WO1997000667A1 (en) * 1995-06-22 1997-01-09 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions
US6623744B2 (en) 1995-06-22 2003-09-23 3M Innovative Properties Company Stable hydroalcoholic compositions
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US6582711B1 (en) * 1997-01-09 2003-06-24 3M Innovative Properties Company Hydroalcoholic compositions thickened using polymers
US6974807B1 (en) * 1997-02-20 2005-12-13 Allergan, Inc. Tazarotene and corticosteroid treatment for psoriasis
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
FI974610A0 (fi) * 1997-12-23 1997-12-23 Leiras Oy Farmaceutiskt preparat i gelform
US8329758B2 (en) * 2002-02-05 2012-12-11 Gojo Industries, Inc. Skin sanitizing antimicrobial alcoholic compositions
KR20040034795A (ko) * 2002-10-17 2004-04-29 박래옥 스테로이드 제제 및 태반 추출물을 함유한 염증성 피부병치료용 경피제
CA2532707A1 (en) 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
WO2006130510A2 (en) 2005-05-27 2006-12-07 Taro Pharmaceuticals U.S.A., Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1957080A4 (en) * 2005-12-09 2013-10-09 Fougera Pharmaceuticals Inc TOPICAL GLUCOCORTICOSTEROID FORMULATIONS
US20090082318A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched mometasone
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2890152A (en) * 1956-11-29 1959-06-09 Schering Corp Topical anti-inflammatory compositions
US3352752A (en) * 1963-07-25 1967-11-14 Tintex Corp Intestinal adsorbent compositions
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US3711606A (en) * 1970-09-02 1973-01-16 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active steroidal agents with dmso
DK135267A (da) * 1971-02-25
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
GB1382614A (en) * 1972-01-10 1975-02-05 Squibb & Sons Inc Steroid compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
US4013792A (en) * 1974-04-11 1977-03-22 Warner-Lambert Company Process for the production of base for topical steroids
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
JPS6013711A (ja) * 1983-06-21 1985-01-24 ザ、プロクタ−、エンド、ギヤンブル、カンパニ− コルチコステロイドを含有する浸透局所製薬組成物
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
US4489071A (en) * 1983-12-09 1984-12-18 Schering Corporation Betamethasone dipropionate cream

Also Published As

Publication number Publication date
IE881517L (en) 1988-11-21
DE3872521D1 (de) 1992-08-06
KR890701109A (ko) 1989-12-19
EP0292893B2 (en) 1995-11-29
AU1941788A (en) 1988-12-21
JPH02501739A (ja) 1990-06-14
FI95350B (fi) 1995-10-13
CA1307207C (en) 1992-09-08
PH24528A (en) 1990-07-18
US4775529A (en) 1988-10-04
MX9203285A (es) 1992-07-01
EP0292893A1 (en) 1988-11-30
NO175762C (no) 1994-12-07
HK60595A (en) 1995-04-28
NZ224707A (en) 1990-09-26
NO890271L (no) 1989-01-20
NO890271D0 (no) 1989-01-20
AU616188B2 (en) 1991-10-24
FI95350C (fi) 1996-01-25
KR930010584B1 (ko) 1993-10-30
NO175762B (no) 1994-08-29
WO1988009174A1 (en) 1988-12-01
IL86440A0 (en) 1988-11-15
EP0362270B2 (en) 1999-11-24
JP2572124B2 (ja) 1997-01-16
ZA883566B (en) 1989-01-25
IL86440A (en) 1993-01-31
ES2032898T3 (es) 1993-03-01
GR3018818T3 (en) 1996-04-30
MY103280A (en) 1993-05-29
GR3005762T3 (en) 1993-06-07
EP0362270B1 (en) 1992-07-01
DE3872521T2 (de) 1992-12-10
EP0362270A1 (en) 1990-04-11
DE3872521T3 (de) 2000-06-21
ATE77745T1 (de) 1992-07-15
ES2032898T5 (es) 1996-03-01
IE60546B1 (en) 1994-07-27
EP0292893B1 (en) 1992-07-01
FI895482A0 (fi) 1989-11-17
DK581989D0 (da) 1989-11-20

Similar Documents

Publication Publication Date Title
DK581989D0 (da) Steroidlotion
EP0242643A3 (en) Nasal administration of drugs
FI891552A0 (fi) Anti-inflammatorisk emulsionssalvakomposition.
NZ183222A (en) Azetidine pyrrolidine-orpiperidine-2-carboxylic acid derivatives and pharmaceutical compositions
FI872231A (fi) Vaetskehaltiga steroidformulationer foer intranasal dosering.
SE7711962L (sv) Forbettrad salva
ES2019634B3 (es) Terapia con clorfeniramina.
IL74853A (en) Transdermally effective topical anti-allergic pharmaceutical compositions comprising azatadine
IE810891L (en) Topical formulation
FR2566662B1 (fr) Association medicamenteuse utilisee en photochimiotherapie
GB1514113A (en) Therapeutic compositions containing dimercapto-diethyl ether derivatives
IT8722713A0 (it) Composizioni farmaceutiche topiche contenenti antiistaminici h2
IE871714L (en) Pharmaceutical compositions for topical administration
IT7922269A0 (it) Preparati di corticosteroidi per somministrazione orale.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment